il.dumitru
TL2 · Osijek
Contributes reviews on supplier material. Based in Osijek.
Joined 13 August 2025 · last posted 1d
86 posts, newest first. Showing up to 150.
-
What published stability data actually covers, and what it does not Replied, post #13 · Practice › Storage & stability · 27 Jul 2026 · 6 likes Published stability data covers a specific formulation at a specific concentration in a specific container. A home-reconstituted preparation matches none of those, and…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #97 · Compounds › Repair & healing peptides · 24 Jul 2026 · 0 likes Coming back to post #95, because the follow-up matters more than the original answer. My understanding of Stability of BPC-157 is a few years old and may have been…
-
Transit times by route, from a logged dataset Replied, post #27 · Sourcing › Logistics · 22 Jul 2026 · 0 likes The practical version of transit times is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #65 · Clinical › Prescriber conversations · 22 Jul 2026 · 14 likes I read post #61 twice before replying, because I had assumed the opposite. What to bring: copies of relevant lab results, pharmacy records (to confirm doses actually…
-
A fridge failure and how I assessed the contents afterwards Replied, post #18 · Devices › Cold chain · 19 Jul 2026 · 0 likes Shipping container and cold packs: reputable suppliers use insulated containers with cold packs designed to arrive cool. Checking on arrival that cold packs are still…
-
Submitting a sample: the process end to end Replied, post #92 · Sourcing › Independent verification · 18 Jul 2026 · 4 likes Worth separating submitting a sample as a question about the compound from submitting a sample as a question about the documentation. They get answered by different…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #12 · Clinical › Prescriber conversations · 18 Jul 2026 · 30 likes On post #10 — agreed on the reasoning, with one qualification. Prescribers reading this subcategory consistently say the most difficult consultations are the ones where…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #6 · Compounds › Oral incretins · 18 Jul 2026 · 0 likes Taking post #3 at face value and following it one step further. The confident answers on PIONEER 6 cardiovascular safety and the well-sourced answers are not the same…
-
Priming a pen and whether the primed volume is wasted Replied, post #7 · Devices › Pens & autoinjectors · 15 Jul 2026 · 1 like Reusability: some pens are single-use (throw away after one injection). Others can be reused until empty. Confirm which type you have. Reusing a single-use pen is…
-
Prescription portability between countries Replied, post #99 · Access › International · 15 Jul 2026 · 12 likes A regional experience posted here should say which year it describes. The archive keeps these permanently and they age faster than anything else on the site.…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #57 · Outcomes › Body composition · 14 Jul 2026 · 10 likes Post #56 is the version of this I will quote in future. One addition. One more thing on ultrasound and skinfolds that took me far too long to see: the two figures…
-
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #13 · Start Here › How to Ask · 11 Jul 2026 · 0 likes I had written a reply contradicting post #9 and deleted it. Here is what survived. It is fine to say you cannot explain why you are asking. Nobody will press, and the…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #75 · Sourcing › Red flags · 5 Jul 2026 · 22 likes Narrowing post #73, because the general version has more than one answer. An honest declaration on supplier: I have a prior here and it is strong enough that you should…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #48 · Clinical › Bloodwork · 24 Jun 2026 · 9 likes I changed my mind about Liver enzymes drifting after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #74 · Compounds › Repair & healing peptides · 18 Jun 2026 · 2 likes The confident answers on Stability of BPC-157 and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #70 · Practice › Storage & stability · 7 Jun 2026 · 23 likes Agreed on peptide, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not, and the…
-
Tracking a shortage from primary sources rather than rumour Replied, post #32 · Access › Shortages · 2 Jun 2026 · 9 likes The published shortage register maintained by the national regulator is the authoritative source here, and it is updated far more often than any thread. Reading it…
-
Travelling with an injectable: documentation and practicalities Replied, post #30 · Access › International · 28 May 2026 · 3 likes A regional experience posted here should say which year it describes. The archive keeps these permanently and they age faster than anything else on the site.
-
A pooled estimate that changed when one trial was added Replied, post #2 · Evidence › Meta-analyses · 22 May 2026 · 27 likes Taking the opening post at face value and following it one step further. I keep a log for pooled estimate specifically because my memory of it turned out to be…
-
Revisiting: Patterns that reliably precede a problem, documented Replied, post #8 · Sourcing › Red flags · 20 May 2026 · 4 likes The strongest single signal available cheaply is what happens when you ask a technical question. A quantitative answer inside a working day is difficult to fake at…
-
Reading a trial's population section before its results Replied, post #16 · Evidence › Trials · 12 May 2026 · 12 likes Picking up post #15: that is the part I would want checked first. Nothing in a trial report is medical advice about an individual, and the gap between a population…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #24 · Analytics › COA interpretation · 2 May 2026 · 0 likes Narrowing post #21, because the general version has more than one answer. A note on how field-by-field walk through a certificate gets discussed rather than on…
-
Official shortage notices and what they authorise Replied, post #29 · Access › Shortages · 1 May 2026 · 31 likes Taking post #27 at face value and following it one step further. International supply chains: a shortage in one country does not mean shortage in another. That is why…
-
List price versus negotiated price versus what you pay Replied, post #38 · Access › Pricing · 11 Apr 2026 · 5 likes For anyone finding this later: the short answer on list price versus negotiated price is that it depends on one thing, and the rest of the thread is people identifying…
-
Spike-and-recover accuracy for a peptide assay Replied, post #69 · Analytics › Method validation · 9 Apr 2026 · 10 likes Filing a mild objection to the consensus on spike-and-recover accuracy. Mild because I might be wrong; an objection because nobody has addressed the case that does not…
-
Follow-up: State-level differences that actually matter Replied, post #31 · Regional › North America · 5 Apr 2026 · 15 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #83 · Pharmacology › Pharmacokinetics · 26 Mar 2026 · 0 likes Adding the measurement that post #80 says would settle it. Where the Washout discussion usually stalls is that nobody wants to say "I do not know" and everyone is…
-
Contributing data without breaching anyone's privacy Replied, post #66 · Data & Tools › Datasets · 6 Mar 2026 · 30 likes That is a cleaner way of putting what I was circling around.
-
What a certificate commits its issuer to — one year on Replied, post #25 · Analytics › COA interpretation · 2 Mar 2026 · 5 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #22 · Compounds › Tirzepatide · 21 Feb 2026 · 21 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #90 · Practice › Dosing & titration · 19 Feb 2026 · 13 likes Escalating before steady state means you are judging a dose you have not yet fully experienced. That is the whole argument against compressing the schedule and it is a…
-
[2026 update] Long-time reader, first-time poster Replied, post #50 · Lounge › Introductions · 12 Feb 2026 · 0 likes What I can speak to on Long-time reader is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #66 · Meta › Site feedback · 8 Feb 2026 · 31 likes Post #65 is right about the mechanism and I think understates the practical bit. Filing a mild objection to the consensus on topic list. Mild because I might be wrong;…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #88 · Access › International · 3 Feb 2026 · 0 likes On Language barriers in accessing the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #74 · Practice › Side effects · 19 Jan 2026 · 15 likes What would change my mind on muscle cramps is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so…
-
Aggregates and why a purity assay may miss them entirely Replied, post #62 · Analytics › Impurities & related substances · 10 Jan 2026 · 7 likes A supplier that can tell you what its principal impurity is has answered a harder question than one that can tell you its purity, and the answer is more useful.
-
Micro-titration: a disputed topic, argued properly Replied, post #19 · Practice › Dosing & titration · 5 Jan 2026 · 4 likes Micro-titration looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #20 · Compounds › Oral incretins · 5 Jan 2026 · 9 likes Adding the measurement that post #19 says would settle it. Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not…
-
Reverse causation in a cohort study of weight and outcome Replied, post #9 · Evidence › Study critique · 30 Dec 2025 · 1 like Post #6 is right about the mechanism and I think understates the practical bit. Reverse causation would be much easier to settle if anyone reported the denominator.…
-
The decimal-point error, and the habit that catches it Replied, post #105 · Practice › Reconstitution · 18 Dec 2025 · 1 like Nobody has said the unglamorous part of decimal-point error yet, so: most of the variation is explained by things that are boring to write about and easy to check.
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #5 · Clinical › Comorbidities · 16 Dec 2025 · 0 likes Having read the whole gastro-oesophageal reflux thread before replying: the question in the first post has not actually been answered yet, and three of us have answered…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #73 · Compounds › Oral incretins · 13 Dec 2025 · 0 likes Building on post #70 rather than restating it. SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in…
-
Personal import allowances, compared — a second dataset Replied, post #31 · Access › International · 4 Dec 2025 · 2 likes Confirming post #30 from a second method, which matters more than confirming it from a second person. Temperature-controlled material and long-haul travel is a…
-
Pen dose counters: what a click does and does not guarantee Replied, post #76 · Devices › Pens & autoinjectors · 17 Nov 2025 · 0 likes Priming: most pens require priming before the first use (injecting a small amount to fill the needle and line). Not priming can result in no dose being delivered on the…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #136 · Practice › Storage & stability · 13 Nov 2025 · 0 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. I have separated what I observed from…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #78 · Analytics › HPLC & UHPLC · 8 Nov 2025 · 2 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
-
Coverage in the US: a map of the usual obstacles Replied, post #8 · Regional › North America · 6 Nov 2025 · 0 likes Confirming post #7 from a second method, which matters more than confirming it from a second person. I would rather this thread reach "we do not know" about coverage…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #122 · Compounds › Tirzepatide · 24 Oct 2025 · 27 likes Post #119 is right about the mechanism and I think understates the practical bit. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide,…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #5 · Outcomes › Body composition · 13 Oct 2025 · 11 likes Good question, well framed, and I would like to see it answered properly.
-
Follow-up: Why appetite effects are mostly central Replied, post #64 · Pharmacology › Receptor biology · 11 Oct 2025 · 0 likes Everything in post #62 holds. The case it does not cover is the one I have. Where I would push back on the appetite effects consensus is the confidence, not the…
-
MHRA statements, read directly Replied, post #11 · Regional › UK & Ireland · 4 Oct 2025 · 14 likes Waiting times are the most variable and least generalisable thing reported here, and they are worth posting anyway with a region and a date.
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #62 · Compounds › Other compounds · 3 Oct 2025 · 6 likes On post #58 — agreed on the reasoning, with one qualification. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which…
-
Revisiting: Power cut for eleven hours: how I assessed it afterwards Replied, post #2 · Practice › Storage & stability · 28 Sep 2025 · 13 likes Confirming the opening post from a second method, which matters more than confirming it from a second person. Speaking only to Power cut for eleven hours as I have…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #105 · Compounds › Secretagogues & GH axis · 27 Aug 2025 · 2 likes Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds or the preparations they are typically supplied in…
-
Travel coolers and how long they really hold Replied, post #17 · Devices › Cold chain · 1 Aug 2025 · 20 likes Coming back to post #15, because the follow-up matters more than the original answer. A cold pack still solid on day seven is a genuinely good sign about the packing…
-
How to research a compound with no human data without deceiving yourself Replied, post #16 · Compounds › Other compounds · 30 Jul 2025 · 24 likes Confirming post #15 from a second method, which matters more than confirming it from a second person. Where a compound has a legitimate pharmaceutical form somewhere in…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #33 · Compounds › Semaglutide · 27 Jul 2025 · 12 likes Post #29 and I disagree about the size of the effect, not about the direction. If someone has run semaglutide versus liraglutide properly I would rather read that than…
-
What a documentation review can and cannot tell you Replied, post #9 · Sourcing › Independent verification · 19 Jun 2025 · 3 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #124 · Data & Tools › Calculators · 9 Jun 2025 · 5 likes Narrowing post #123, because the general version has more than one answer. Checking a tool against a worked example you already trust is five minutes well spent, and it…
-
Albumin binding and how it produces a long half-life Replied, post #42 · Pharmacology › Pharmacokinetics · 30 May 2025 · 27 likes Terminal half-life estimated from a short sampling window underestimates the true value. That is a common source of discrepant figures between sources.
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #45 · Practice › Storage & stability · 20 May 2025 · 16 likes Two claims get bundled together under published stability data actually covers and they need separating. The descriptive one — this is what was observed — is usually…
-
A ten-fold dose error caught before injection Replied, post #30 · Devices › Syringes & needles · 6 May 2025 · 6 likes What would change my mind on ten-fold dose error caught is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would…
-
Coverage for the indication versus for the drug Replied, post #51 · Access › Insurance & coverage · 3 May 2025 · 2 likes Quantity limits are a separate decision from coverage and have their own exception route. Happy to be corrected if someone holds better data than mine.
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #81 · Sourcing › Red flags · 16 Apr 2025 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Cost per milligram, computed honestly across formats — the long version Replied, post #55 · Access › Pricing · 5 Apr 2025 · 2 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
A certificate with no method stated: what can you conclude? Replied, post #25 · Analytics › COA interpretation · 3 Apr 2025 · 0 likes Asking for the batch record rather than the certificate is a reasonable request and the response to it is informative whichever way it goes.
-
An emergency department visit, described afterwards Replied, post #7 · Safety › Adverse events · 29 Mar 2025 · 11 likes Post #5 describes the usual case. This is about the unusual one. What would change my mind on emergency department visit is a second dataset collected by someone with…
-
Revisiting: Why I ask for the gradient before I discuss the number Replied, post #2 · Analytics › HPLC & UHPLC · 24 Mar 2025 · 11 likes Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
-
Requesting a page: what makes a good request Replied, post #31 · Documentation › Wiki requests · 22 Mar 2025 · 0 likes Post #28 answers the question as asked. The question underneath it is different. Link the topics that prompted the request. The discussion is the evidence that the…
-
Counter-ion content and its effect on measured mass Replied, post #3 · Analytics › Mass spectrometry · 19 Mar 2025 · 28 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
Reading order for a first week here, and what to skip until later Replied, post #6 · Start Here › Welcome · 16 Feb 2025 · 14 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #39 · Compounds › Semaglutide · 25 Jan 2025 · 0 likes My understanding of published dose-response for semaglutide is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #10 · Compounds › Tirzepatide · 25 Jan 2025 · 6 likes On tirzepatide in type 2 diabetes, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the…
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #14 · Pharmacology › Receptor biology · 29 Dec 2024 · 23 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #4 · Compounds › Secretagogues & GH axis · 25 Dec 2024 · 0 likes Effects reported at the level of appetite are the most consistently described and the most mechanistically direct for the ghrelin-receptor compounds, which is not what…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #13 · Practice › Reconstitution · 21 Dec 2024 · 0 likes On reconstituting a multi-strength kit: the maintained page in the documentation commons covers the general case with citations and a review date, which is more…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #16 · Data & Tools › Calculators · 11 Dec 2024 · 11 likes Significant figures in the output should not exceed what the inputs support. A concentration calculated from a nominal vial mass is not known to four decimal places.
-
Washout with a one-week half-life: the arithmetic Replied, post #72 · Research Methods › N-of-1 designs · 5 Dec 2024 · 7 likes Order effects matter. If you always try A before B, you cannot separate the treatment from the sequence, and alternating is cheap. That distinction has done more work…
-
Reading a supplementary appendix and finding the interesting part Replied, post #34 · Evidence › Trials · 30 Nov 2024 · 19 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #29 · Compounds › Repair & healing peptides · 10 Nov 2024 · 19 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
Second pass at: When a network meta-analysis is defensible and when it is not Replied, post #3 · marked as the solution · Evidence › Meta-analyses · 4 Nov 2024 · 21 likes Picking up the opening post: that is the part I would want checked first. A network meta-analysis rests on a transitivity assumption that is rarely tested and is…
-
Blind submission and why it changes minds Replied, post #93 · Sourcing › Independent verification · 20 Oct 2024 · 0 likes The claim about blind submission upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #5 · Compounds › Retatrutide · 26 Aug 2024 · 9 likes Post #4 is the version of this I will quote in future. One addition. What I would want before treating hepatic effects of glucagon receptor as settled: the method, the…
-
Correlation in a self-tracked dataset: what it can support Started this topic · Research Methods › Statistics · 19 Aug 2024 · 2 likes Correlation in a self-tracked dataset: what it can support — setting out what I have, and where I think it stops being reliable. Posting a small dataset on correlation.…
-
The mass-error checker and its intended scope Replied, post #114 · Data & Tools › Calculators · 11 Jul 2024 · 20 likes The question underneath mass-error checker is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #17 · Practice › Dosing & titration · 6 Jul 2024 · 12 likes Adding a null result on Splitting a weekly dose. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.